Scientists on the Street

Do scientists who are hired as say, biotech equity analysts, need a Ph D to get started? MBA? Both? Would investment banks rather hire a Ph D fresh out of grad school or a BS with a few years of work experience at a biotech/pharmaceutical company? Thanks.

7 Comments
 

They don't need a PhD but I guess it helps? I know someone who started in ER at UBS after a Chem Engineering PhD, but had no other previous financial experience.

 

Most banks have little need for people with science training. Maybe at the upper level it helps in a healthcare group, but overall not so much. A science PhD or MD would add much more value at a hedge fund or PE shop because at those places, you need to understand products much more so than in banking, which is more capital structure-focused. I used to work for a healthcare hedge fund / PE shop, and every single person there (except one) had either a PhD, MD, MBA or two of the above. I'd suggest looking into PE, VC, and hedge funds if you want to apply science training to Wall Street.

 
Best Response

m0nk3y, i believe that the original poster was referring to equity research, not ibd. no ph.d is necessary for equity research, but a serious science background is pretty much needed to be on a biotech or pharma ER team. at the bank i did my sa er stint at, the only sa in biotech did his undergrad in biomedical engineering (he decided against wall street and is now getting a ph.d). in addition during that summer, the bank also hired a full-timer to work in biotech straight from a research position. he had a ph.d from columbia.

this is not the case for teams covering, for instance, managed care and medical supplies.

 

Deleniti sed tempora aut quis. Est et ipsa possimus illo. Officia repudiandae quas quod vitae. Molestiae iusto aut voluptatem eos voluptatem. Sapiente error voluptatem facere accusamus pariatur.

Ut ipsum excepturi ullam corrupti. Dolor assumenda architecto quibusdam maxime cumque blanditiis cum. Illo repellat totam est temporibus sed. Dolorum aliquam impedit quo aut non esse.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Guggenheim Partners 01 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”